Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04626453
Other study ID # STUDY00004297
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 29, 2020
Est. completion date June 27, 2021

Study information

Verified date September 2021
Source State University of New York at Buffalo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine the physiological evidence of how muscular and cerebral oxygenation changes link to fatigue, physical, and cognitive performance after moderate-intensity exercise in sedentary older adults with type 2 diabetes.


Description:

This is an experimental design. One intervention group will do exercise for 2 months and be measured twice, at baseline, and after 2 months. The other 2 control groups will be assessed just once without exercise intervention. Our primary objective is to clarify physiological evidence of how muscular and cerebral oxygenation changes in sedentary older adults with diabetes after low-to-moderate intensity exercise. The secondary objective is to determine fatigue, physical, cognitive performance changes, blood glucose level among sedentary older adults with diabetes after low-to-moderate intensity exercise.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date June 27, 2021
Est. primary completion date June 27, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - For the intervention group, the inclusion criteria are - sedentary older adults 60 years or older who are living in their homes in the community - diagnosed type 2 diabetes - ambulatory with or without mobility devices such as a cane and/or walker - Be able to follow simple exercise instructions without assistance. - For the comparison group, the inclusion criteria are - individuals aged 60 years or older who are living in their homes, in the community; - ambulatory with or without devices; - able to follow simple exercise instructions without assistance - able to walk six minutes as quickly as possible without any adverse symptoms including extreme pain on feet or joints, dizziness, vertigo, or nausea. Exclusion Criteria: - For the intervention group, the exclusion criteria are - foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders - current smoking or smoking within the last 12 months - current cardiopulmonary diseases, vascular disease, or stroke - dementia indicating the inability to follow exercise instructions independently - those who are currently or plan to receive physical therapy in the following three months - individuals without English proficiency will be excluded - If the individuals with blood glucose level are over 400 mg/dL or HbA1C > 8.0%, and - type 1 diabetes. For the comparison group, the exclusion criteria are - individuals who have prediabetes, diabetes, or current cardiopulmonary diseases and stroke - current smoking or smoking within the last 12 months - individuals with foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders, and dementia.

Study Design


Intervention

Behavioral:
2-month home moderate-intensity exercise
The 2-month exercise will be conducted at the participants' homes. Participants will be recommended to perform the combined exercise, which consists of the resistance exercise and walking at a faster speed than leisure walking at a moderate-intensity, for 6 days/week. They can decide which day they won't perform the exercise. Participants will be encouraged to do progressive resistance exercise and walking twice a day, once in the morning and the other time in the afternoon. Resistance exercise will be suggested to perform every other day for three days/week and walking as the aerobic exercise will be on alternate days for three days/week.

Locations

Country Name City State
United States University at Buffalo Buffalo New York

Sponsors (1)

Lead Sponsor Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary normalized ?SmO2 rate a parameter of muscular oxygenation to indicate the match or mismatch between oxygen supply and oxygen demand during the physical stimulus. measure twice, at baseline and after 2 months
Primary recovery time a parameter of muscular oxygenation, time taken in seconds after the exercise to back to the beginning oxygenation level. measure twice, at baseline and after 2 months
Primary Resting SmO2 a parameter of muscular oxygenation, the average oxygenation level in % while sitting still for 3 minutes before doing physical performance tests. measure twice, at baseline and after 2 months
Primary Oxyhemoglobin differences a parameter of cerebral oxygenation, the difference of the oxyhemoglobin in mL per gram before and after the cognitive tests. measure twice, at baseline and after 2 months
Secondary Fatigue Fatigue will be assessed by the Numeric Fatigue Scale (NFS) by selecting a number from 0 to 10. 0 is no fatigued at all, 10 is extremely fatigued. measure twice, at baseline and after 2 months
Secondary Timed Up and Go test score in seconds An assessment of physical performance. Time in seconds from sitting up from a chair, walking to 3 meters, turning, walking back to sitting down on a chair. measure twice, at baseline and after 2 months
Secondary Short Physical Performance Battery An assessment of physical performance. This test contains three sections: balance, walking speed and chair stand. The scores are 0-12. measure twice, at baseline and after 2 months
Secondary Bilateral Heel Raise test An assessment of physical performance. This test askes to do heel raise to the maximum height continuously. Time to fatigued in seconds and the frequencies of heel raise are recorded. measure twice, at baseline and after 2 months
Secondary 6 Minute Walking Test An assessment of physical performance. The test assesses time in seconds when participants walk as fast as they can in 6 minutes. measure twice, at baseline and after 2 months
Secondary Mini-cog test An assessment of cognitive performance. A Short term memory test. measure twice, at baseline and after 2 months
Secondary Trail Making Test An assessment of cognitive performance. A executive function test. measure twice, at baseline and after 2 months
Secondary blood glucose level in mg/dL Blood glucose level before and after exercise measure twice, at baseline and after 2 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2